Integrating a biorepository into the National Amyotrophic Lateral Sclerosis Registry
|D. Kevin Horton , Wendy Kaye , Laurie Wagner 
Agency for Toxic Substances and Disease Registry, Division of Toxicology and Human Health Sciences
|Journal of Environmental Health
|ALS is a rare disease. Obtaining biospecimens is important to further research efforts and obtaining biospecimens on an ongoing basis can be challenging for researchers. ATSDR conducted a 4-year long pilot study to test the practicality, utility, and feasibility of creating a national biorespository of pre- and post-mortem biospecimens from PALS. As the Registry is the largest cohort of PALS in the U.S., it is the ideal group to attempt to collect biologic specimens on a large geographically representative group of PALS.
|Link to paper
|Find the paper herepdf icon!
Page last reviewed: July 14, 2021
Content source: Agency for Toxic Substances and Disease Registry